-
2-(2-Aminothiazole-4-yl)-2-methoxyiminoacetic acid CAS:65872-41-5
2-(2-Aminothiazole-4-yl)-2-methoxyiminoacetic acid is a chemical compound with potential applications in various fields. It is used as an intermediate in the synthesis of pharmaceuticals, agrochemicals, and dyes. Due to its unique chemical structure, it has drawn interest in the research and development of new materials and processes.
-
Thymopentin CAS:69558-55-0
Thymopentin is a synthetic pentapeptide that mimics a naturally occurring thymic hormone, thymopoietin. It is known for its immunomodulatory effects and is used to support immune function in conditions characterized by immunodeficiency or impaired T-cell function.
-
Teriparatide Acetate CAS:52232-67-4;99294-94-7
Teriparatide acetate is indicated for the treatment of osteoporosis in postmenopausal women at high risk for fracture, as well as in men with primary or hypogonadal osteoporosis who are at increased risk of fractures. It is also approved for the treatment of osteoporosis in individuals who have failed or cannot tolerate other osteoporosis therapies.
-
Teduglutide CAS:197922-42-2
Teduglutide is a glucagon-like peptide-2 (GLP-2) analog used for the treatment of short bowel syndrome in adults. It works by promoting intestinal adaptation, enhancing nutrient absorption, and reducing dependency on parenteral support.
-
Octreotide Acetate CAS:79517-01-4
Octreotide acetate is a synthetic analog of the natural hormone somatostatin, primarily used in the treatment of acromegaly, carcinoid tumors, and vasoactive intestinal peptide-secreting tumors. It works by inhibiting the release of certain hormones and neurotransmitters, thereby helping to reduce symptoms associated with these conditions. Octreotide acetate is available in injectable and long-acting release formulations, providing flexibility in the management of various disorders.
-
Somatostatin CAS:51110-01-1
Somatostatin is a naturally occurring hormone that inhibits the release of various other hormones in the body. It plays a crucial role in regulating the endocrine system and is involved in the control of growth hormone, insulin, glucagon, and other gastrointestinal hormones.
-
Linaclotide CAS:851199-59-2
Linaclotide is a guanylate cyclase-C agonist indicated for the treatment of chronic constipation and irritable bowel syndrome with constipation in adults. It works locally in the gastrointestinal tract to increase fluid secretion and accelerate intestinal transit, alleviating symptoms associated with these conditions.
-
Levosimendan CAS:141505-33-1
Levosimendan is a calcium sensitizer and potassium channel opener used for the management of acute decompensated heart failure. This medication has inotropic and vasodilatory effects, improving cardiac function and relieving symptoms of heart failure.
-
Liraglutide CAS:204656-20-2
Liraglutide is a medication used to treat type 2 diabetes and obesity. It belongs to the class of drugs known as glucagon-like peptide-1 (GLP-1) receptor agonists, which work by increasing insulin production and decreasing the amount of sugar produced by the liver. Liraglutide is available in injectable form and is typically administered once daily. The medication has been shown to help lower blood sugar levels and promote weight loss in people with type 2 diabetes and obesity.
-
Octreotide Acetate CAS:83150-76-9
Octreotide acetate is a synthetic octapeptide analog of the natural hormone somatostatin. It acts as a potent inhibitor of various hormones and neuropeptides, and it is used in the management of conditions such as acromegaly, carcinoid syndrome, and certain types of tumors.
-
Semaglutide CAS:910463-68-2
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used for the management of type 2 diabetes and obesity. It works by regulating blood sugar levels, promoting weight loss, and reducing cardiovascular risk.
-
Icatibant Acetate CAS:138614-30-9
Icatibant acetate is a medication used for the treatment of hereditary angioedema (HAE), a rare genetic condition characterized by sudden and severe swelling of the skin, mucous membranes, and other body tissues. It is a selective bradykinin B2 receptor antagonist that works by blocking the effects of bradykinin, a key mediator of the swelling associated with HAE. Icatibant acetate is administered via subcutaneous injection and is designed to rapidly relieve symptoms of acute HAE attacks.
